Literature DB >> 1790214

Experimental infections of mice and pigs with Streptococcus suis type 2.

Y Kataoka1, M Haritani, M Mori, M Kishima, C Sugimoto, M Nakazawa, K Yamamoto.   

Abstract

Five inbred strains of mice were tested for their susceptibility to Streptococcus suis type 2 including the type strain, two isolates from meningitis in pigs and two isolates from tonsils of clinically healthy pigs. C57BL/6, ICR and ddY strain mice showed lower susceptibility to all strains of S. suis type 2 than BALB/c and SS strain mice. The type strain and the isolates from diseased pigs produced septicaemia and meningitis in BALB/c and SS mice inoculated with 10(8) colony forming unit of the bacteria and 60 to 100% of these infected mice died. On the other hand, mice inoculated with the isolates from healthy pigs showed mild clinical signs but none of them died. In BALB/c mice which died or developed nervous signs, the purulent meningo-encephalitis, myocarditis, ophthalmitis, labyrinthitis and otitis media were observed. S. suis type 2 antigen was demonstrated in these lesions by immunoperoxidase staining using rabbit S. suis type 2 antiserum. These results were similar to those in the experimentally infected pigs with these virulent and avirulent strains against mice. These results indicate that BALB/c and SS strains of mice are useful as an experimental model of S. suis type 2 infections in pigs, and that there are virulent and avirulent strains against mice and pigs among the strains of S. suis type 2.

Entities:  

Mesh:

Year:  1991        PMID: 1790214     DOI: 10.1292/jvms.53.1043

Source DB:  PubMed          Journal:  J Vet Med Sci        ISSN: 0916-7250            Impact factor:   1.267


  13 in total

1.  Dilemma of the virulence of Strptococcus suis strains.

Authors:  M Gottschalk; R Higgins; S Quessy
Journal:  J Clin Microbiol       Date:  1999-12       Impact factor: 5.948

2.  Antibody response specific to the capsular polysaccharide is impaired in Streptococcus suis serotype 2-infected animals.

Authors:  Cynthia Calzas; Paul Lemire; Gael Auray; Volker Gerdts; Marcelo Gottschalk; Mariela Segura
Journal:  Infect Immun       Date:  2014-11-10       Impact factor: 3.441

Review 3.  Streptococcus suis: past and present.

Authors:  J J Staats; I Feder; O Okwumabua; M M Chengappa
Journal:  Vet Res Commun       Date:  1997-08       Impact factor: 2.459

Review 4.  Mouse models for human otitis media.

Authors:  Dennis R Trune; Qing Yin Zheng
Journal:  Brain Res       Date:  2009-03-06       Impact factor: 3.252

5.  Comparison of the susceptibilities of C57BL/6 and A/J mouse strains to Streptococcus suis serotype 2 infection.

Authors:  María de la Cruz Domínguez-Punaro; Mariela Segura; Danuta Radzioch; Serge Rivest; Marcelo Gottschalk
Journal:  Infect Immun       Date:  2008-06-23       Impact factor: 3.441

6.  Production of capsular material by Streptococcus suis serotype 2 under different growth conditions.

Authors:  M Gottschalk; R Higgins; M Jacques
Journal:  Can J Vet Res       Date:  1993-01       Impact factor: 1.310

7.  Partial characterization of Streptococcus suis type 2 hemolysin.

Authors:  I Feder; M M Chengappa; B Fenwick; M Rider; J Staats
Journal:  J Clin Microbiol       Date:  1994-05       Impact factor: 5.948

8.  Discrimination of virulent and avirulent Streptococcus suis capsular type 2 isolates from different geographical origins.

Authors:  S Quessy; J D Dubreuil; M Caya; R Higgins
Journal:  Infect Immun       Date:  1995-05       Impact factor: 3.441

9.  Isolation, characterization and protection studies in mice of a streptomycin-dependent mutant of Streptococcus suis type 1/2.

Authors:  N Foster; J J Staats; M M Chengappa
Journal:  Vet Res Commun       Date:  1994       Impact factor: 2.459

10.  Comparison of pig, rabbit and mouse IgG response to Streptococcus suis serotype 2 proteins and active immunization of mice against the infection.

Authors:  S Quessy; J D Dubreuil; M Caya; R Létourneau; R Higgins
Journal:  Can J Vet Res       Date:  1994-07       Impact factor: 1.310

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.